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Abstract
Background: The B cell antigen receptor (BCR) and pathogen recognition receptors, such as Toll-like receptor 4
(TLR4), act in concert to control adaptive B cell responses. However, little is known about the signaling pathways
that integrate BCR activation with intrinsic TLR4 stimulation. Antigen receptors initialize activation of the inducible
transcription factor nuclear factor-B (NF-B) via recruitment of the membrane-associated guanylate kinase caspase
recruitment domain protein 11 (CARD11), the adapter molecule B cell CLL/lymphoma 10 (BCL10), and the
“paracaspase” mucosa-associated lymphoid tissue lymphoma translocation gene 1 (MALT1) into lipid rafts. Upon
BCR triggering, this activation strictly depends on BCL10, but not on MALT1, leading to the hypothesis that a
MALT1-independent NF-B activation pathway contributes to BCR-induced NF-B activation downstream of BCL10.
The identity of this pathway has remained elusive.
Results: Using genetic and biochemical approaches, we demonstrate that the IRAK4- and IRAK1-dependent TLR
signaling branch is activated upon BCR triggering to induce partial NF-B activation. BCR-induced MALT1-
independent IB degradation and B cell proliferation were inhibited in MALT1/IRAK4 double knockout B cells.
Moreover, IRAK1 was recruited into lipid rafts upon BCR stimulation and activated following transient recruitment
of IRAK4.
Conclusion: We propose that the observed crosstalk between BCR and TLR signaling components may contribute
to the discrimination of signals that emanate from single and dual receptor engagement to control adaptive B cell
responses.
Background
Activation and survival of B cells in response to antigen
receptor (AgR) engagement depends on the activation of
the inducible transcription factor NF-B. BCR-induced
NF-B activation is mediated by components of the
so-called CBM signaling complex. The CBM complex
consists of the CARD-containing membrane-associated
guanylate kinase CARD11, the CARD-containing adaptor
protein BCL10, and the death domain (DD)-containing
“paracaspase” MALT1 [1-5]. Complex assembly and the
recruitment of downstream effectors are triggered by a
receptor-proximal tyrosine phosphorylation cascade that
leads to the activation of protein kinase C-b (PKC-b)
[6,7]. PKC-b phosphorylates a linker region in the adap-
tor molecule CARD11, which enables CARD11 to recruit
BCL10 and MALT1 into lipid rafts [8]. BCL10 and
MALT1 then mediate activation of the IKK complex that
induces degradation of IB proteins, the inhibitors of
NF-B that retain it in the cytoplasm, which ultimately
leads to the activation of NF-B [9]. This process
requires lysine 63-linked polyubiquitination events that
involve the E3-ligase tumor necrosis factor receptor-asso-
ciated factor 6 (TRAF6) and mediate complex formation
between components of the CBM complex, TRAF6,
transforming growth factor b-activated kinase 1 (TAK1)
and the IKK complex [10-13].
Paradoxical to the established requirement of MALT1
for T cell AgR (TCR)-mediated proliferation and NF-B
activation, BCR-driven proliferation and IB degradation
are reduced, but not abrogated in MALT1-deficient B
* Correspondence: almut.dufner@uniklinik-freiburg.de
1Campbell Family Institute for Breast Cancer Research, 620 University
Avenue, Toronto, Ontario, M5G 2C1, Canada
Full list of author information is available at the end of the article
Dufner and Schamel Cell Communication and Signaling 2011, 9:6
http://www.biosignaling.com/content/9/1/6
© 2011 Dufner and Schamel; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.cells, even though the impact on B cell proliferation was
contradictory among previous reports [3-5,14]. In con-
trast, BCL10-deficient B cells exhibit complete inhibition
of proliferation and IB degradation in response to BCR
engagement [3,4,14]. These findings have been attribu-
ted to the differential activation of the NF-B subunits
RelA and c-Rel. In BCL10-/- B cells both subunits
remain bound to undegraded IBa following BCR acti-
vation, whereas in MALT1-/- cells only the activation of
c-Rel-containing NF-B dimers is affected [3]. These
results suggested the presence of an alternative,
MALT1-independent BCR-induced NF-B activation
pathway capable of activating RelA downstream of
BCL10.
TLRs are responsible for the recognition of pathogen-
associated molecular patterns expressed by extracellular
pathogens. Toll-like receptor 4 (TLR4) is the prototypic
TLR that recognizes lipopolysaccharide (LPS) derived
from the outer membrane of gram-negative bacteria
[15]. It relays signals to NF-B via two pathways, one
branch involving the Toll-interleukin-1 receptor (TIR)
domain-containing adapter proteins TIRAP and MyD88,
which in turn recruit the DD-containing kinases inter-
leukin receptor-associated kinase 4 (IRAK4) and IRAK1.
IRAK1 then activates NF-B in a signaling pathway that
utilizes many components of AgR-induced NF-Ba c t i -
vation downstream of MALT1. Alternatively, TLR4 acti-
vates NF-B via the TIR domain-containing adaptor
inducing interferon-b (TRIF) and receptor-interacting
protein 1 (RIP1) [16].
One study using MALT1-/- mice suggested that
MALT1 is required for TLR4-induced B cell prolifera-
tion [5]. A parallel study did not confirm a defect in
TLR4 signaling in MALT1-/- B cells [4]. This discre-
pancy could be due to different MALT1 knockout (KO)
strategies, which may point to a crosstalk between BCR-
and TLR4-mediated NF-B activation in B cells. Indeed,
previous reports have indicated that the BCL10-MALT1
pathway interacts with TLR4 signaling. BCL10 has been
shown to be important for LPS signaling to NF-Bi n
marginal zone B cells [17]. In addition, it has been
reported that BCL10 and MALT1 are part of NF-B-
inducing signaling complexes downstream of TLR4
receptors in macrophages [18,19]. Conversely, IRAK4
has been suggested to play a critical role in TCR-
induced NF-B activation upstream of PKCθ [20]. This
hypothesis has recently been challenged by others, how-
ever, who could not confirm a defect in TCR-induced
ex vivo proliferation of IRAK4-/- T cells [21,22].
Signaling by pathogen recognition receptors (PRRs) of
the innate immune system has been shown to be essen-
tial for the initiation of efficient adaptive T and B cell
responses [23,24]. We have demonstrated that induced
proximity of the BCR and the PRR TLR4 by antigen-
coupled LPS results in a synergistic increase in B cell
activation [25]. The finding that TLR4 may associate
with the BCR via its transmembrane domain [26] adds
further evidence to a receptor-proximal signaling
crosstalk.
Here we examined whether an IRAK4-dependent
mechanism is required for MALT1-independent BCR
signaling downstream of BCL10. To test this hypothesis,
we generated MALT1/IRAK4 double knockout (DKO)
bone marrow (BM) chimera and compared their BCR
activation potential to that of MALT1 single KO BM
chimera. In addition, we monitored the lipid raft
recruitment and activation of IRAK4 and IRAK1 in
response to BCR activation. Our results demonstrate
that mediators of the TLR4 signaling pathway to NF-B
are engaged upon BCR activation to contribute to B cell
proliferation.
Results
MALT1 and IRAK4 independently mediate antigen
receptor-induced B cell proliferation
To reassess the role of MALT1 in B cell activation, we
purified splenic B cells from MALT1+/- and MALT1-/-
mice and stimulated them with anti-IgM antibodies, or
anti-IgM plus anti-CD40, or LPS. In agreement with
earlier studies, IgM-BCR-induced NF-B activation
translated into partial long term B cell proliferation in
MALT1-/- B cells [3,4], although the observed inhibition
of proliferation was more severe than suggested by some
of the earlier reports [4,14] (Figure 1A). Moreover, LPS-
induced MALT1-/- B cell proliferation was not signifi-
cantly affected (Figure 1A and data not shown). As
shown previously [4,5], MALT1-/- B cells exhibited sub-
stantial, yet partially impaired short term degradation of
IBa in response to BCR engagement (Figure 1B). Anti-
IgM-induced activation of the MAP kinases ERK1 and
ERK2 was not affected in the absence of MALT1 (Figure
1B). These results confirm that BCR-stimulated IBa
degradation is at least in part MALT1-independent.
Next, we examined whether B cell proliferation in
response to IgM-BCR stimulation or through both IgM-
BCR and CD40 is affected in IRAK4-/- mice. To gener-
ate mice with lymphocyte-specific deletion of IRAK4, we
reconstituted RAG1-/- mice with BM from IRAK4-/-
mice or from WT mice. Consistent with a role for
IRAK4 in BCR signaling, IRAK4-/- B cells exhibited par-
tial hypoproliferation in response to anti-IgM stimula-
tion in the absence or the presence of anti-CD40
(Figure 2A). Thymidine incorporation into IRAK4-/- B
cells, which was monitored in six independent experi-
ments, was reduced by approximately 30% compared to
WT B cells (Figure 2A). LPS-induced B cell proliferation
was almost completely inhibited in the absence of
IRAK4. In line with the minor defect in anti-IgM-
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IBa degradation and phosphorylation appeared to be
normal in IRAK4-/- B cells (Figure 2B). Again, ERK
activation was unaffected. In summary, these results
indicate that IRAK4 is important for efficient BCR-
induced B cell expansion.
In parallel experiments, we monitored the activation
potential of WT and IRAK4-deficient T cells from
lymph nodes of the same reconstituted RAG1-/- mice
(Figure 2C). It has been argued that IRAK4 is specifi-
cally required for T cell activation by weak signals such
as stimulation by soluble anti-CD3 antibody [27]. To
distinguish between quantitative and qualitative differ-
ences in stimulation signals, we exposed T cells to either
soluble antibodies and agonists alone or in the presence
of irradiated WT splenocytes to provide additional co-
stimulatory signals. Independently of signal strength, we
did not observe any significant differences in T cell acti-
vation by stimulation with anti-CD3 in the absence or
presence of anti-CD28, or with TPA plus Ca
2+ iono-
phore A23187 (Figure 2C). In conclusion, IRAK4
specifically contributes to the AgR-mediated activation
of B cells.
To test whether IRAK4 is involved in BCR signaling in
a manner that is independent of MALT1, we compared
the BCR activation potential of MALT1-/- B cells to
that of B cells lacking both MALT1 and IRAK4.
MALT1/IRAK4 DKO mice did not display any gross
developmental defects, but died within one week after
weaning (not shown). Presumably, young MALT1/
IRAK4 DKO mice succumb to infections due to the lack
of breast feeding-mediated passive immunity after wean-
ing. The percentage of splenic MALT1/IRAK4 DKO B
lymphocytes (B220
+) was slightly reduced compared to
the percentage of MALT1 KO B220
+ lymphocytes
(Figure 3A). The mean difference between single and
double KO littermates amounts to 9.2% (std. dev.: 5.7%;
P < 0.05). In contrast, percentages of splenic IgM
+IgD
-
and IgM
+IgD
+ B cells were not significantly altered
(Figure 3A). Likewise, there were no significant differ-
ences in the percentages of follicular or marginal zone B
cells, or pre/pro B cells in the BM between the two gen-
otypes (data not shown).
For the B cell activation experiments, we reconstituted
RAG1-/- mice with BM from MALT1 KO or MALT1/
IRAK4 DKO mice. Isolation and stimulation of splenic
B cells with anti-IgM or anti-IgM plus anti-CD40
revealed severe inhibition of the expansion of MALT1-
deficient B cells if IRAK4 was also absent (Figure 3B).
In line with this result, degradation of IB was dimin-
ished in MALT1/IRAK4 DKO cells compared to
MALT1 KO cells (Figure 3C). Activation of ERK was
not affected by the absence of IRAK4.
We have also monitored JNK activation for further
analysis of the observed BCR-TLR4 signaling crosstalk
(Figure 3D). Similar to NF-B activation, JNK activa-
tion has been reported to be completely impaired in
MALT1-/- T cells that have been stimulated with
PMA/ionomycin in one report [4]. These data are in
conflict with another report, however, showing normal
JNK phosphorylation in PMA/ionomycin-stimulated
MALT1-/- T cells [5]. In MALT1-/- B cells, BCR-
mediated activation of the JNK downstream effector
AP-1 is not affected [4]. We have monitored AP-1
activation in MALT1 single KO and MALT1/IRAK4
double KO B cells that have been stimulated with anti-
IgM for 6 hours. Consistent with a role for IRAK4 in
MALT1-independent AP-1 activation, our data demon-
strate that AP-1 activation is partially inhibited in anti-
IgM stimulated MALT1/IRAK4 double KO B cells
compared to MALT1 single KO B cells. As expected,
AP-1 activation by LPS was blocked in the absence of
IRAK4 [28].
T h e s ed a t ae s t a b l i s hI R A K 4a sam o d u l a t o ro fB C R
signaling that is independent of MALT1 function.
Figure 1 Activation of BCR signaling in MALT1-/- B cells.( A)B
cell proliferation. Splenic MALT1+/- and MALT1-/- B cells were
stimulated for 36 h with soluble anti-IgM, anti-IgM plus anti-CD40,
or LPS. Proliferation was measured by [
3H]thymidine incorporation.
Results are presented as the mean [
3H]thymidine incorporation ± S.
D. for triplicate samples after an 8 h pulse and are 1 trial
representative of at least 3 independent experiments. (B)I Ba
degradation. Splenic MALT1+/- and MALT1-/- B cells were
stimulated for the indicated times with anti-IgM. IBa degradation,
ERK1/2 phosphorylation (P-ERK), and actin levels were determined
by Western blotting.
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To examine whether the IRAK4-dependent pathway is
directly involved in BCR signaling to NF-B, we asked
whether components of this signaling cascade are
recruited into lipid rafts after BCR engagement. To this
end, we isolated lipid rafts by sucrose gradient ultracen-
trifugation and controlled the experiment by Western
blotting against phospho-ERK and MALT1 and dot
blotting against the raft-resident ganglioside GM1. We
observed substantial accumulation of IRAK1 in lipid
rafts of splenic WT B cells that were stimulated with
anti-IgM for at least 2 minutes (Figure 4A). In contrast,
our time course experiment revealed that IRAK4 and
MALT1 get recruited into lipid rafts transiently. At two
minutes post BCR stimulation, IRAK4 raft-accumulation
was detected that declined after 5 minutes. In contrast,
membrane-associated IRAK1 levels remained elevated
for at least 10 minutes post BCR stimulation. In the
context of TLR signaling IRAK1 gets recruited, phos-
phorylated and activated by IRAK4 to relay signals to
NF-B. Hence, our results imply that BCR activation
not only causes recruitment of IRAK4 and IRAK1 into
lipid rafts, but also leads to IRAK1 activation.
To test whether the activation state of IRAK1 changes
upon BCR triggering, we monitored its autophosphory-
lation in IgM-BCR-stimulated B cells. It should be
noted, however, that the functional relevance of the
kinase activity of IRAK1 is still uncertain [29]. In agree-
ment with a direct effect of BCR stimulation on IRAK1
activity, we observed a transient increase of IRAK1
autophosphorylation in response to anti-IgM stimulation
(Figure 4B). As a control, we treated B cells with the
Figure 2 B and T cell activation in the absence of IRAK4.( A) Partial defect in BCR-induced B cell expansion in the absence of IRAK4. Splenic
IRAK4+/+ and IRAK4-/- B cells from RAG1-/- mice reconstituted with IRAK4+/+ or IRAK4-/- BM cells were stimulated as in Figure 1A. Proliferation
was measured by [
3H]thymidine incorporation. Results are presented as the mean [
3H]thymidine incorporation ± S.D. for 6 independent
experiments after an 8 h pulse. The data were analyzed using the dependent (paired samples) t-test. (B)I Ba degradation after anti-IgM
stimulation of IRAK4-/- B cells. Splenic IRAK4+/+ and IRAK4-/- B cells from reconstituted RAG1-/- mice were stimulated as in Figure 1B and IBa
degradation and phosphorylation (P-IBa), ERK1/2 phosphorylation and actin levels were analyzed by Western blotting. (C) Normal TCR-induced
proliferation of IRAK4-/- T cells. Upper panel: Purified IRAK4+/+ and IRAK4-/- T cells from reconstituted RAG1-/- mice were stimulated for the
indicated times with anti-CD3 in the absence or presence of anti-CD28, or with TPA/Ca
2+ ionophore A23187 (I). Lower panel: Purified T cells
were mixed with irradiated WT splenocytes and stimulated as in the upper panel. For both sets of panels, proliferation was measured as in (A).
Results are presented as the mean [
3H]thymidine incorporation ± S.D. for 3 independent experiments after an 8 h pulse.
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tor of TLR4 in B cells than the conventional “smooth
form” S-LPS [25,30]. ReLPS stimulation resulted in a
more rapid autophosphorylation of IRAK1 than anti-
IgM stimulation. Unlike ERK activation, which peaked
after 5 minutes of ReLPS stimulation, IRAK1 autopho-
sphorylation was stimulated within the first minute of
exposure and was back to basal levels five minutes post
stimulation.
In summary, these results demonstrate that the BCR
relays signals to IRAK4 and IRAK1, which ultimately
leads to the lipid raft recruitment and enzymatic activa-
tion of IRAK1.
Discussion
Using genetic and biochemical approaches, we show
that IRAK4 and IRAK1 are involved in BCR-induced
NF-B activation (Figure 5). Until now, these kinases
were known for being definitive mediators of signaling
by members of the IL-1 receptor and TLR families [31].
More recently, they have been suggested to transmit sig-
nals to NF-B in response to activation of the tumor
necrosis factor receptor (TNFR) familiy member trans-
membrane activator and calcium modulator and cyclo-
philin ligand interactor (TACI) to control T cell-
independent class-switch recombination [32]. It is con-
ceivable that the observed involvement in BCR signaling
is mediated by direct interactions with the CBM com-
plex or by an adaptor molecule that bridges BCL10
recruitment to the recruitment of IRAK4-containing
complexes into lipid rafts. Pellino proteins have been
shown to function as E3 ubiquitin ligases that target
IRAK1 to regulate the recruitment of the IKK complex
[33]. Interestingly, one group found that both IRAK1
and Pellino-2 directly interact with BCL10 [18,19]. They
suggest that IRAK1 cooperates with BCL10 and MALT1
in the TLR4 signaling pathway to NF-B in RAW264.7
macrophages [19]. Pellino-2 transcripts are not detected
in adult mouse spleen, however [34]. Further investiga-
tion into the identification and analysis of CBM-inter-
acting proteins is required to establish the precise
mechanism that couples pathways triggered by the BCR
to components of TLR-induced signal transduction
cascades.
Activation of the IRAK4/IRAK1 axis by the BCR is not
sufficient to overcome the defects in signaling and cellu-
lar expansion caused by the absence of a functional
MALT1 subcomplex, however. Deletion of MALT1 may
lead to the generation of a non-functional complex, in
which c-Rel-containing dimers are kept in an inactive
state. Likewise, IRAK4/IRAK1 signals may specifically
allow nuclear translocation and activation of the RelA-
containing subset of NF-B transcription factors inde-
pendently of MALT1’s organizer function that has been
hypothesized to specifically promote the interaction of
the IKK complex with c-Rel-bound IB [3]. Third, BCR-
activated IRAK4 may induce both c-Rel and RelA-con-
taining NF-B dimers with slower kinetics than MALT1
thereby compromising more efficient B cell activation in
the absence of a TLR4 signal.
Vice versa, there appears to be residual IBd e g r a d a -
tion even in the absence of MALT1 and IRAK4. Similar
to MALT1, caspase 8 is critical for efficient TCR-
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Figure 3 B cell activation defects in the absence of MALT1 and
IRAK4.( A) Flow cytometric analysis of splenic MALT1 KO and
MALT1/IRAK4 DKO lymphocytes. Upper panel: Percentages of B220
+
lymphocytes; the data were analyzed using the dependent (paired
samples) t-test (n = 5). Lower Panel: Percentages of IgM single or
IgM/IgD double positive B220
+ splenocytes. (B) Splenic MALT1 KO
and IRAK4/MALT1 DKO B cells from RAG1-/- mice reconstituted with
MALT1 KO or MALT1/IRAK4 DKO BM cells were stimulated as in
Figure 1A and the proliferative response was measured accordingly.
Results are presented as the mean [
3H]thymidine incorporation ± S.
D. for triplicate samples after an 8 h pulse and are 1 trial
representative of at least 3 independent experiments. (C) Splenic
MALT1 KO and MALT1/IRAK4 DKO B cells from reconstituted
RAG1-/- mice were stimulated and analyzed by Western Blotting as
in Figure 1B. (D) Splenic MALT1 KO and MALT1/IRAK4 DKO B cells
from reconstituted RAG1-/- mice were stimulated with soluble anti-
IgM or LPS for 6 hours and AP-1 activation was determined by
Electrophoretic Mobility Shift Assay (EMSA).
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term NF-B activation [36], but not for anti-IgM-
induced proliferation of B cells [37]. It has been sug-
gested that MALT1-directed cleavage of the caspase 8
regulator c-Flip by caspase 8 contributes to NF-Ba c t i -
vation after TCR-induced recruitment of caspase 8 into
lipid rafts [38]. The latter model places caspase 8 down-
stream of the MALT1 paracaspase domain in TCR sig-
naling, however, which contradicts the model that puts
the NF-B signaling bifurcation point at the level of
BCL10. It remains to be clarified, whether caspase 8
plays a role in the TRIF-dependent branch of TLR4-
induced NF-B activation. This pathway is mediated by
the IRAK family-related kinase RIP1, another candidate
that may participate in a crosstalk between receptors of
innate and adaptive immunity. Such crosstalk has
already been proposed for the RIP kinase family
member RIP2, a mediator of NF-B activation by the
intracellular PRRs for bacterial peptidoglycan nucleo-
tide-binding oligomerization domain containing 1
(NOD1) and NOD2. A previous report indicated that
RIP2 directly interacts with BCL10, and T cell activation
was initially reported to be impaired in RIP2-/- cells
[39]. Even though these findings have later been attribu-
ted to undetected NOD signaling that is important for
priming of an adaptive immune response [24], they may
point to a common theme of B cell-intrinsic crosstalk
between receptor proximal BCR and PRR signaling.
More recently, MALT1 has been shown to be required
for activation of the alternative NF-B signaling pathway
by B cell activation factor of the TNF family (BAFF),
which is required for BAFF receptor-mediated B cell sur-
v i v a l[ 1 4 ] .C o u p l e dB C R - T L R 4r e c o g n i t i o no nt h eo t h e r
hand may promote synergistic effects on B cell activation
[25] via recruitment of additional signaling molecules
into a dual-receptor proximal supercomplex (Figure 5).
Conclusions
Signaling modules that activate NF-Bd o w n s t r e a mo f
TLR4 are engaged upon BCR activation. Our findings
have important implications for the integration of signals
downstream of the BCR and the subset of TLRs that tar-
get IRAK4 to mediate adequate antibody responses.
Methods
Mouse strains
The MALT1-/- and IRAK4-/- mice were in the C57BL/6
background and have been described previously [4,28].
Figure 4 Lipid raft recruitment and activation of IRAK1 and IRAK4.( A) Lipid raft recruitment of IRAK1 and IRAK4. Splenic WT B cells were
left unstimulated or were stimulated for the indicated times with anti-IgM. Lysates were separated by sucrose-gradient ultracentrifugation and
the indicated amounts of the collected fractions were analyzed by Western blotting with antibodies to IRAK1, MALT1, IRAK4, and phospho-ERK.
To identify the lipid raft containing samples, 5 μl of each fraction were spotted onto a nitrocellulose membrane and GM1 was visualized with
FITC-labeled Cholera toxin. (B) Activation of IRAK1 upon BCR triggering. Splenic WT B cells were stimulated for the indicated times with anti-IgM
or ReLPS. The kinase activity of immunoprecipitated IRAK1 was measured by an autophosphorylation assay. IRAK1, phospho-ERK1/2, and actin
were quantified by Western blotting of the lysates. IP, immunoprecipitation; WB, Western blotting.
BCR TLR4
MALT1
CARD11 BCL10 IRAK4/IRAK1
p50/c-Rel
p50/RelA
Signal Integration
Figure 5 NF-B activation in B cells. Proposed signal integration
during BCR and TLR4 crosstalk. Differential (sequential) complex
configuration is indicated by the use of complementary colors.
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Ontario Cancer Institute or the Max-Planck-Institute of
Immunobiology and Epigenetics according to institu-
tional protocols.
RAG1-/- reconstitution
RAG1-/- mice were g-irradiated with a dose of 600 rad
and penicillin/streptomycin was added to the drinking
water. The next day, the mice were injected with 2.5 -
5×1 0
6 BM cells. BM from tibias and femurs was
obtained by flushing with PBS containing 1% FCS and
depleted of red blood cells (RBCs) using RBC lysis buffer
(Sigma Aldrich). The reconstituted mice were kept on
antibiotics for 2 weeks and analyzed after 2-3 months.
T and B cell isolation, stimulation and proliferation assays
T and B cells were maintained in RPMI 1640 medium
containing 10% FCS, 100 μgm l
-1 penicillin/streptomy-
cin, and 50 μM b-mercaptoethanol. T cells were purified
using IMag Streptavidin Particles Plus - DM (BD Phar-
mingen). For the proliferation and stimulation experi-
ments, B cells were isolated with biotinylated anti-CD19
antibody (BD Pharmingen) and IMag Streptavidin Parti-
cles Plus - DM as described before [40]. For T cell pro-
liferation assays, 10
5 T cells were stimulated in 96-well
U-bottom plates in the presence or absence of 10
5 irra-
diated (30 Gy) unfractionated WT splenocytes. For T
cell stimulation, anti-CD3 (145-2C11, BD Pharmingen)
and anti-CD28 (553294, BD Pharmingen) were used at a
concentration of 1 μgm l
-1. Alternatively, T cells were
stimulated with 10 ng ml
-1 TPA (Sigma) plus 50 ng ml
-1
Ca
2+ ionophore A23187 (Sigma). For B cell proliferation
assays, purified B cells (5-10 × 10
4) were stimulated by
incubation with 5 μgm l
-1 anti-IgM [F(ab’)2 fragment,
115-006-020, Jackson ImmunoResearch Laboratories]
with or without 5 μgm l
-1 anti-CD40 (553787, BD Phar-
mingen), or 20 μgm l
-1 ultra pure E. coli LPS (Invivo-
Gen). [
3H]thymidine incorporation was measured as
described before [40]. For short term stimulation experi-
ments, B cells were activated by preincubation with
anti-IgM (10 μgm l
-1) for 30 min on ice and stimulated
for the times indicated at 37°C. LPS short term stimula-
tion was performed with 25 μgm l
-1 ReLPS [30].
Immunoprecipitation, kinase assay, Western blotting and
EMSA
Cells were lysed as described previously [41]. Protein
lysates were precleared with protein G sepharose 4B
(Sigma) and subsequently proteins were immunoprecipi-
t a t e db yc o m b i n i n gs o l u b l ec e l ll y s a t ew i t hp r o t e i nG
sepharose 4B coupled to the mouse monoclonal IRAK1
(F-4) antibody (Santa Cruz Biotechnology). After 2 h
incubation at 4°C with constant rotation, immunoprecipi-
tates were washed 3 times with lysis buffer and once with
kinase buffer (25 mM Tris-HCl, pH 7.5; 10 mM MgCl2;5
mM b-glycerophosphate; 1 mM sodium vanadate).
Kinase assays were performed in kinase buffer in the pre-
sence of 10 μCi [g
32P]ATP and 10 μM cold ATP. Reac-
tions were incubated at 37°C for 30 min and stopped by
addition of SDS-PAGE loading buffer. Western blot ana-
lysis was performed using antibodies recognizing phos-
pho-p44/42 MAP kinase (Thr202/Tyr204) (#9101, Cell
Signaling), IBa (#9242, Cell Signaling), or phospho-
IBa (Ser32) (#9241, Cell Signaling), actin (A-2066,
Sigma), IRAK1 (F-4, Santa Cruz Biotechnology), IRAK4
(Acris), MALT1 (H-300, Santa Cruz Biotechnology) and
secondary horseradish peroxidase-coupled antibodies.
Monosialotetrahexosylganglioside (GM1) was visualized
with the FITC-conjugated Cholera Toxin B Subunit (C-
1655, Sigma). The EMSA was performed using the Odys-
sey Infrared EMSA Kit and AP-1 probes from LI-COR.
Lipid raft preparations
B-cells (6 spleens per stimulation) were purified with
IMag Streptavidin Particles Plus by anti-CD43 (553269,
BD Biosciences) depletion and were either left untreated
or stimulated with anti-IgM for the indicated times. The
cells were lysed in 750 μl cold 1% Brij lysis buffer and
mixed with 750 μl 85% sucrose made with MNE buffer
(25 mM MES, pH 6.5; 150 mM NaCl; 5 mM EDTA).
After transfer of the lysate to the centrifuge tube, 1.5 ml
35% sucrose in MNE buffer was overlaid, then 1 ml 5%
sucrose in MNE buffer. After centrifugation for 16 h at
39,000 rpm in a Sorvall Ultracentrifuge OTD-C (Ultra-
Rotor Sorvall AH-650), 0.4 ml fractions were collected
from the top of the gradient.
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